Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Roper

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Nature|June 14, 2019
Pluripotency and the origin of animal multicellularityShunsuke Sogabe, William L Hatleberg, Kevin M Kocot, et al.
MMWR. Morbidity and Mortality Weekly Report|June 15, 2023
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023Danielle L Moulia, Megan Wallace, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2023
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Jefferson M Jones, Katherine E Fleming-Dutra, Mila M Prill, et al.
Obstetrics and Gynecology Clinics of North America|May 6, 2023
Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and InfantsKatherine E Fleming-Dutra, Lauren Head Zauche, Lauren E Roper, et al.
Vaccine|January 31, 2025
Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approachRyan E Wiegand, Owen Devine, Megan Wallace, et al.
Vaccine|September 6, 2024
Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virusDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
MMWR. Morbidity and Mortality Weekly Report|August 15, 2024
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024Amadea Britton, Lauren E Roper, Camille N Kotton, et al.
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
Advances in Marine Biology|June 2, 2014
Transitions during cephalopod life history: the role of habitat, environment, functional morphology and behaviourJean-Paul Robin, Michael Roberts, Lou Zeidberg, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nature|June 14, 2019
Pluripotency and the origin of animal multicellularityShunsuke Sogabe, William L Hatleberg, Kevin M Kocot, et al.
MMWR. Morbidity and Mortality Weekly Report|June 15, 2023
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023Danielle L Moulia, Megan Wallace, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2023
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Jefferson M Jones, Katherine E Fleming-Dutra, Mila M Prill, et al.
Obstetrics and Gynecology Clinics of North America|May 6, 2023
Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and InfantsKatherine E Fleming-Dutra, Lauren Head Zauche, Lauren E Roper, et al.
Vaccine|January 31, 2025
Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approachRyan E Wiegand, Owen Devine, Megan Wallace, et al.
Vaccine|September 6, 2024
Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virusDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
MMWR. Morbidity and Mortality Weekly Report|August 15, 2024
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024Amadea Britton, Lauren E Roper, Camille N Kotton, et al.
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
Advances in Marine Biology|June 2, 2014
Transitions during cephalopod life history: the role of habitat, environment, functional morphology and behaviourJean-Paul Robin, Michael Roberts, Lou Zeidberg, et al.
Pageof 6